Clinical and laboratory test in patients with familial amyloid polyneuropathy: differences between symptomatic patients and asymptomatic carriers

Benzer Materyaller

• Transthyretin familial amyloid polyneuropathy (TTR-FAP) in Mallorca: a comparison between late- and early-onset disease
  Yazar:: Raya-Cruz, Manuel, ve diğerleri
  Baskı/Yayın Bilgisi: (2015)
• Epidemiology of transthyretin-associated familial amyloid polyneuropathy in the Majorcan area: Son Llàtzer Hospital descriptive study
  Yazar:: Reinés, Juan Buades, ve diğerleri
  Baskı/Yayın Bilgisi: (2014)
• Management of asymptomatic gene carriers of transthyretin familial amyloid polyneuropathy
  Yazar:: Schmidt, Hartmut H.‐J., ve diğerleri
  Baskı/Yayın Bilgisi: (2016)
• Clinical Characteristics of Immune Response in Asymptomatic Carriers and Symptomatic Patients With COVID-19
  Yazar:: Li, Entao, ve diğerleri
  Baskı/Yayın Bilgisi: (2022)
• Psychopathological dimensions in familial amyloid polyneuropathy patients
  Yazar:: Lopes, Alice, ve diğerleri
  Baskı/Yayın Bilgisi: (2015)